Larvol Delta - BenevolentAI-Doses-First-Participants-in-Clinical-Trial-of-BEN8744-Targets-PDE10-an-AIderived-Novel-Target-for-the-Treatment-of-Ulcerative-Colitis

BEN-8744 - BenevolentAI

https://www.businesswire.com/news/home/20230830333577/en/BenevolentAI-Doses-First-Participants-in-Clinical-Trial-of-BEN-8744-Targets-PDE10-an-AI-derived-Novel-Target-for-the-Treatment-of-Ulcerative-Colitis

Aug 31, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next